Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetofetal Transfusion | 34 | 2025 | 194 | 8.750 |
Why?
|
| Fetoscopy | 37 | 2025 | 447 | 4.300 |
Why?
|
| Fetal Diseases | 12 | 2025 | 457 | 3.520 |
Why?
|
| Pregnancy, Twin | 29 | 2025 | 180 | 3.400 |
Why?
|
| Pregnancy | 85 | 2025 | 7215 | 3.020 |
Why?
|
| Ultrasonography, Prenatal | 26 | 2025 | 972 | 2.910 |
Why?
|
| Fetal Growth Retardation | 9 | 2025 | 238 | 2.020 |
Why?
|
| Laser Therapy | 10 | 2023 | 249 | 1.930 |
Why?
|
| Fetus | 13 | 2023 | 586 | 1.890 |
Why?
|
| Twins, Monozygotic | 11 | 2025 | 117 | 1.830 |
Why?
|
| Meningomyelocele | 9 | 2025 | 250 | 1.790 |
Why?
|
| Anemia | 4 | 2023 | 341 | 1.770 |
Why?
|
| Premature Birth | 13 | 2023 | 387 | 1.710 |
Why?
|
| Gestational Age | 33 | 2025 | 1169 | 1.700 |
Why?
|
| Amniotic Fluid | 6 | 2025 | 150 | 1.650 |
Why?
|
| Blood Transfusion, Intrauterine | 4 | 2024 | 37 | 1.510 |
Why?
|
| Pregnancy Outcome | 19 | 2025 | 596 | 1.400 |
Why?
|
| Neural Tube Defects | 7 | 2024 | 356 | 1.350 |
Why?
|
| Retrospective Studies | 48 | 2025 | 16334 | 1.240 |
Why?
|
| Infant, Newborn | 36 | 2025 | 8272 | 1.230 |
Why?
|
| Laser Coagulation | 11 | 2024 | 129 | 1.210 |
Why?
|
| Female | 86 | 2025 | 66669 | 1.170 |
Why?
|
| Oligohydramnios | 2 | 2025 | 46 | 1.120 |
Why?
|
| Rh Isoimmunization | 2 | 2024 | 28 | 1.080 |
Why?
|
| Pregnancy Complications | 2 | 2022 | 515 | 1.080 |
Why?
|
| Polyhydramnios | 2 | 2025 | 56 | 1.080 |
Why?
|
| Urethral Obstruction | 3 | 2023 | 56 | 1.070 |
Why?
|
| Fetal Death | 5 | 2023 | 112 | 1.010 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 5 | 2025 | 399 | 1.000 |
Why?
|
| Teratoma | 2 | 2024 | 126 | 1.000 |
Why?
|
| Umbilical Arteries | 4 | 2021 | 98 | 0.930 |
Why?
|
| Sacrococcygeal Region | 1 | 2024 | 32 | 0.910 |
Why?
|
| Diseases in Twins | 2 | 2021 | 94 | 0.890 |
Why?
|
| Pleural Effusion | 1 | 2024 | 102 | 0.860 |
Why?
|
| Prenatal Diagnosis | 5 | 2025 | 602 | 0.830 |
Why?
|
| Fetal Therapies | 4 | 2025 | 80 | 0.820 |
Why?
|
| Humans | 86 | 2025 | 125025 | 0.810 |
Why?
|
| Placenta Previa | 1 | 2023 | 66 | 0.790 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 50 | 0.790 |
Why?
|
| Spinal Dysraphism | 3 | 2023 | 270 | 0.780 |
Why?
|
| Walking | 2 | 2024 | 216 | 0.760 |
Why?
|
| Magnesium Sulfate | 2 | 2021 | 48 | 0.750 |
Why?
|
| Polycythemia | 3 | 2024 | 44 | 0.740 |
Why?
|
| Cerebral Ventricles | 2 | 2024 | 82 | 0.730 |
Why?
|
| Adult | 34 | 2025 | 29452 | 0.730 |
Why?
|
| Ascites | 1 | 2021 | 93 | 0.710 |
Why?
|
| Hysterotomy | 5 | 2025 | 126 | 0.680 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 51 | 0.680 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.660 |
Why?
|
| Anemia, Hemolytic | 1 | 2019 | 30 | 0.660 |
Why?
|
| Prospective Studies | 13 | 2023 | 6122 | 0.640 |
Why?
|
| Spectrin | 1 | 2019 | 62 | 0.620 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2019 | 57 | 0.580 |
Why?
|
| Pregnancy Reduction, Multifetal | 4 | 2022 | 20 | 0.580 |
Why?
|
| Lower Extremity | 1 | 2019 | 178 | 0.570 |
Why?
|
| Placenta | 7 | 2023 | 507 | 0.570 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 45 | 0.570 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 439 | 0.520 |
Why?
|
| Cohort Studies | 11 | 2024 | 4819 | 0.510 |
Why?
|
| Lung | 6 | 2025 | 1490 | 0.460 |
Why?
|
| Perinatal Death | 2 | 2023 | 26 | 0.420 |
Why?
|
| Hydrocephalus | 3 | 2024 | 244 | 0.400 |
Why?
|
| Pregnancy, Triplet | 2 | 2022 | 10 | 0.390 |
Why?
|
| Lasers | 8 | 2024 | 114 | 0.390 |
Why?
|
| Treatment Outcome | 12 | 2025 | 12269 | 0.380 |
Why?
|
| Fetal Blood | 2 | 2023 | 173 | 0.380 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 127 | 0.360 |
Why?
|
| Airway Obstruction | 2 | 2023 | 164 | 0.340 |
Why?
|
| Fetal Weight | 4 | 2023 | 61 | 0.320 |
Why?
|
| Infant | 9 | 2025 | 12610 | 0.290 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 501 | 0.290 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2023 | 166 | 0.280 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 2181 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2025 | 3597 | 0.270 |
Why?
|
| Logistic Models | 3 | 2021 | 1800 | 0.270 |
Why?
|
| Laparotomy | 2 | 2024 | 135 | 0.260 |
Why?
|
| Trachea | 3 | 2023 | 203 | 0.250 |
Why?
|
| Prenatal Care | 3 | 2023 | 348 | 0.240 |
Why?
|
| Edema | 2 | 2023 | 136 | 0.240 |
Why?
|
| Postoperative Complications | 3 | 2021 | 3044 | 0.240 |
Why?
|
| Umbilical Cord | 2 | 2022 | 57 | 0.230 |
Why?
|
| Parvoviridae Infections | 1 | 2024 | 36 | 0.230 |
Why?
|
| Organ Size | 3 | 2025 | 442 | 0.220 |
Why?
|
| Twins | 2 | 2021 | 69 | 0.220 |
Why?
|
| Placental Insufficiency | 1 | 2024 | 15 | 0.220 |
Why?
|
| Hernia, Umbilical | 1 | 2024 | 42 | 0.220 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2021 | 60 | 0.220 |
Why?
|
| Sutures | 1 | 2024 | 64 | 0.220 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2023 | 27 | 0.220 |
Why?
|
| Carbon Dioxide | 2 | 2023 | 279 | 0.210 |
Why?
|
| Spina Bifida Cystica | 1 | 2024 | 35 | 0.210 |
Why?
|
| Urinary Tract | 1 | 2023 | 60 | 0.210 |
Why?
|
| Abruptio Placentae | 1 | 2022 | 16 | 0.200 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 46 | 0.200 |
Why?
|
| Leptin | 1 | 2024 | 213 | 0.200 |
Why?
|
| Fetal Development | 2 | 2024 | 132 | 0.200 |
Why?
|
| Chorioamnionitis | 1 | 2022 | 42 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 223 | 0.190 |
Why?
|
| Child Development | 1 | 2025 | 269 | 0.190 |
Why?
|
| Placenta Diseases | 1 | 2022 | 59 | 0.190 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 237 | 0.190 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 62 | 0.190 |
Why?
|
| Intestinal Atresia | 1 | 2022 | 19 | 0.190 |
Why?
|
| Tocolytic Agents | 1 | 2021 | 12 | 0.190 |
Why?
|
| Middle Cerebral Artery | 1 | 2022 | 114 | 0.190 |
Why?
|
| Maryland | 1 | 2021 | 30 | 0.190 |
Why?
|
| Indomethacin | 1 | 2021 | 83 | 0.190 |
Why?
|
| Hemangioma | 1 | 2022 | 94 | 0.180 |
Why?
|
| Respiratory System Abnormalities | 1 | 2022 | 42 | 0.180 |
Why?
|
| Waist Circumference | 1 | 2021 | 89 | 0.180 |
Why?
|
| Patient Handoff | 1 | 2021 | 24 | 0.180 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 80 | 0.180 |
Why?
|
| Rhabdoid Tumor | 1 | 2021 | 53 | 0.180 |
Why?
|
| Extraembryonic Membranes | 1 | 2020 | 14 | 0.170 |
Why?
|
| Simulation Training | 1 | 2022 | 140 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 138 | 0.170 |
Why?
|
| Incidence | 4 | 2021 | 3130 | 0.170 |
Why?
|
| Uterine Rupture | 1 | 2020 | 18 | 0.170 |
Why?
|
| Myometrium | 1 | 2020 | 47 | 0.170 |
Why?
|
| Delphi Technique | 1 | 2021 | 210 | 0.170 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 76 | 0.170 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2020 | 49 | 0.170 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 132 | 0.170 |
Why?
|
| Cervical Length Measurement | 1 | 2019 | 5 | 0.170 |
Why?
|
| Lung Volume Measurements | 3 | 2025 | 75 | 0.170 |
Why?
|
| Gastroschisis | 1 | 2020 | 55 | 0.170 |
Why?
|
| Fetal Heart | 1 | 2020 | 120 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 454 | 0.160 |
Why?
|
| Cicatrix | 1 | 2020 | 124 | 0.160 |
Why?
|
| Twins, Conjoined | 1 | 2019 | 29 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2021 | 353 | 0.150 |
Why?
|
| Siblings | 1 | 2019 | 186 | 0.150 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 251 | 0.150 |
Why?
|
| Steroids | 1 | 2019 | 202 | 0.150 |
Why?
|
| ROC Curve | 1 | 2020 | 571 | 0.150 |
Why?
|
| Papillary Muscles | 1 | 2018 | 20 | 0.150 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2018 | 6 | 0.150 |
Why?
|
| Travel | 1 | 2019 | 115 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2021 | 222 | 0.150 |
Why?
|
| Light Coagulation | 3 | 2023 | 24 | 0.150 |
Why?
|
| Cannula | 1 | 2018 | 27 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2022 | 385 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2024 | 1016 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3310 | 0.140 |
Why?
|
| Young Adult | 6 | 2021 | 9054 | 0.140 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 104 | 0.140 |
Why?
|
| Mass Screening | 1 | 2023 | 783 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5167 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1684 | 0.140 |
Why?
|
| Survival Rate | 1 | 2022 | 2051 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 190 | 0.130 |
Why?
|
| Anxiety | 1 | 2023 | 944 | 0.130 |
Why?
|
| Sepsis | 1 | 2021 | 483 | 0.130 |
Why?
|
| Mitral Valve | 1 | 2018 | 252 | 0.130 |
Why?
|
| Texas | 2 | 2021 | 3571 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 490 | 0.130 |
Why?
|
| Pedigree | 1 | 2019 | 1610 | 0.130 |
Why?
|
| Male | 8 | 2025 | 61429 | 0.130 |
Why?
|
| Child, Preschool | 5 | 2024 | 14150 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2020 | 783 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1893 | 0.120 |
Why?
|
| Recurrence | 1 | 2018 | 1388 | 0.120 |
Why?
|
| Depression | 1 | 2023 | 1233 | 0.110 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 313 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 605 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2017 | 781 | 0.100 |
Why?
|
| Hydrops Fetalis | 2 | 2023 | 74 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2021 | 1178 | 0.090 |
Why?
|
| Cervix Uteri | 2 | 2023 | 63 | 0.090 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 129 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2021 | 433 | 0.090 |
Why?
|
| Child | 4 | 2023 | 24609 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2016 | 1563 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2021 | 81 | 0.080 |
Why?
|
| Birth Weight | 2 | 2022 | 346 | 0.080 |
Why?
|
| Age Factors | 1 | 2016 | 2815 | 0.080 |
Why?
|
| Hypertension | 1 | 2017 | 1286 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2021 | 1496 | 0.070 |
Why?
|
| Mutation | 1 | 2019 | 5897 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2024 | 40 | 0.060 |
Why?
|
| Polyesters | 1 | 2024 | 39 | 0.060 |
Why?
|
| Materials Testing | 1 | 2024 | 72 | 0.060 |
Why?
|
| Heart Failure | 1 | 2017 | 2297 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4683 | 0.050 |
Why?
|
| Parturition | 1 | 2023 | 63 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 10278 | 0.050 |
Why?
|
| Watchful Waiting | 1 | 2023 | 69 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 236 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 273 | 0.050 |
Why?
|
| Duodenal Obstruction | 1 | 2022 | 13 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 66 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2023 | 241 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 20 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2021 | 43 | 0.050 |
Why?
|
| Perinatal Care | 1 | 2022 | 67 | 0.050 |
Why?
|
| Multilevel Analysis | 1 | 2020 | 8 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 120 | 0.040 |
Why?
|
| Encephalocele | 1 | 2021 | 50 | 0.040 |
Why?
|
| Placental Circulation | 1 | 2020 | 24 | 0.040 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 43 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 57 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2021 | 357 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 240 | 0.040 |
Why?
|
| Transient Tachypnea of the Newborn | 1 | 2019 | 2 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2022 | 288 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 146 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 129 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2020 | 193 | 0.040 |
Why?
|
| Resuscitation | 1 | 2022 | 252 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2019 | 216 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 759 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 776 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 49 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 704 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 1252 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 390 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2018 | 110 | 0.040 |
Why?
|
| Estradiol | 1 | 2019 | 527 | 0.030 |
Why?
|
| Estrogens | 1 | 2019 | 503 | 0.030 |
Why?
|
| Rats | 1 | 2024 | 3723 | 0.030 |
Why?
|
| Progesterone | 1 | 2019 | 621 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2019 | 207 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 503 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 726 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 222 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 185 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 835 | 0.030 |
Why?
|
| United States | 2 | 2021 | 10884 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1630 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1114 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Proteins | 1 | 2019 | 1037 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2019 | 833 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2876 | 0.030 |
Why?
|
| Adolescent | 2 | 2022 | 19412 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 3012 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 26670 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 34205 | 0.010 |
Why?
|